Skip to content
‹ Back to IndustriesHealthcare

Capsa's RoboPharma HV Wall is the first central fill system confirmed compatible with Parcel Health's paper vials

Capsa Healthcare says its RoboPharma HV Wall is the first central fill automation system confirmed to fill Parcel Health’s Tully Tube, a paper prescription vial. The confirmation matters because central fill and mail order sites can only use containers their machines can handle—but this applies to the HV Wall specifically and is not a named production deployment. Buyers can see the vials at ASHP Midyear, Dec. 6–9.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

By MarketScale Newsroom · Capsa HealthcareParcel HealthTully TubeRobopharma Hv Wall
Share
Capsa's RoboPharma HV Wall is the first central fill system confirmed compatible with Parcel Health's paper vials

Key takeaways

01

A central fill site can't switch to a paper vial its automation can't handle. Confirmed machine compatibility is the gate, and the RoboPharma HV Wall is the first system through it for the Tully Tube.

02

The up to 71 percent plastic reduction per unit is a ceiling measured against a similar-size plastic vial, so operators modeling sustainability targets should ask for the comparison basis for their own vial sizes.

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Eight billion. That's Parcel Health's estimate of how many plastic prescription vials get thrown away in the United States every year. Until this week, no central fill automation system had been confirmed to fill the company's paper replacement.

Capsa Healthcare and Parcel Health announced on Nov. 19 that the Tully Tube, Parcel's paper prescription vial, has been confirmed compatible with Capsa's RoboPharma HV Wall, which runs on the HV Cell. That makes the HV Wall the first central fill system to receive this confirmation. PR Newswire carried the joint release. In a report the same day, Thorvardur de Shong of Chain Drug Review wrote that the deal gives pharmacies a practical alternative to plastic packaging on automated lines.

The person this lands on is whoever runs a central fill or mail order site and answers for both throughput and the company's packaging commitments. For that person, the question is simpler than whether paper is greener. It's whether paper can go through the machines already on the floor.

The fill line picks the bottle

The companies' release puts the mechanism plainly: for central fill operators, packaging is a decision made once and then repeated on every order. At a retail counter, a technician can reach for a different container. On an automated line, a container the system can't handle simply isn't an option. A paper vial a central fill operator can't run is a very nice desk ornament.

In central fill, a package gets chosen once and then repeated on every order, which means a paper vial becomes a real option only when a high-volume machine is confirmed to fill it.

Capsa describes RoboPharma as automation designed from the start for central fill, not adapted from retail. Bobbi Jamriska, Capsa's chief product officer, made the same distinction in the release. She said Capsa built its automation specifically for central fill and that working with Parcel Health adds a paper prescription vial to that line. That design history helps explain why the confirmation names a specific system. A vial has to be proven on the exact machine that will handle it. Working on some other machine is not enough.

Melinda Su-En Lee, a trained pharmacist who co-founded Parcel Health and serves as its CEO, made the same point from the vial maker's side. In the release, she said a paper bottle has value only when it works inside the workflows pharmacies already use. She added that the partnership with Capsa makes this possible in central fill automation for the first time. Her stated goal is to make the amber vial "a relic of the past."

Parcel's company description says Lee and Mallory Barrett started the business with a goal of removing plastic from healthcare supply chains, one prescription at a time. The Pittsburgh company, founded and run by women, designs and manufactures sustainable pharmaceutical packaging. Parcel says the Tully Tube is the world's first paper prescription bottle to satisfy both regulatory and operational requirements, and the only one to do so.

Capsa adds scale to that goal. According to the company, its central fill technology handles more than 550,000 prescriptions every day, and its users include some of the biggest central fill and mail order operations in the world. One point needs care here. The compatibility confirmation covers the HV Wall specifically. The 550,000 figure therefore reflects Capsa's total central fill footprint and does not show how many prescriptions could switch to paper tomorrow.

The partner is not a newcomer to the floor. Capsa, based in Canal Winchester, Ohio, has worked in pharmacy automation since 1971. Its global team numbers more than 500 people, with locations in Waalwijk, the Netherlands; Agua Prieta, Mexico; and Portland, Oregon. Beyond central fill, its portfolio covers retail pharmacy, clinical supply chain, point-of-care technologies and medication management.

The numbers behind the paper vial

8 billion
Plastic prescription vials discarded in the US each year, Parcel Health's estimate of the waste it is targeting
Up to 71%
Less plastic per Tully Tube than a similar-size plastic vial, a ceiling and not an average
550,000+
Prescriptions filled daily on Capsa's central fill technology across its installed base

Parcel Health and Capsa Healthcare, via PR Newswire

Paper bags, digital guides and the vial itself

The vial is one piece of a larger package. Capsa's automated packing and labeling already fills paper bags instead of plastic ones and prints QR codes that link to digital medication guides, cutting out printed inserts. Jamriska said in the release that the package leaving the fill line is part of the job. Paired with the Tully Tube, that lets an operator take plastic and printed paper out of the whole order, beyond the container alone.

According to Parcel Health, the Tully Tube resists humidity and water and blocks light. Its child-resistant cap is reversible and includes an easy-open option. The vial can go in curbside recycling, and pharmacies and health systems can have it custom-printed with their own branding. On Oct. 15, TIME put it on its Best Inventions of 2026 list in the Medical & Healthcare category.

A QR code on the bottom of each vial opens Doorstep, Parcel's patient page. Patients can set text medication reminders, find refill links back to their pharmacy and read cap instructions without downloading an app or creating an account. For mail order operations, where the package that shows up at the door is the main physical contact with the patient, that refill link could matter as much as the material the vial is made of.

"Confirmed compatible" here means the RoboPharma HV Wall, powered by the HV Cell, can fill the Tully Tube. Capsa's paper bag filling and QR code printing for digital medication guides come from its separate packing and labeling automation, so a full paper order involves more than one piece of equipment.

Where the read has limits

The strongest objection to calling this a turning point is that it is one confirmation on one system. Operators running other automation get no direct benefit yet, and the announcement describes compatibility, not a named customer site running paper vials in production.

Parcel's own claims cover different ground from Capsa's. The "first and only" description concerns the bottle meeting regulatory and operational requirements; the HV Wall confirmation concerns whether one high-volume machine can fill it. An operator weighing a switch needs both to hold for their own site.

The plastic math also deserves a second look. Up to 71 percent less plastic per unit is a best case measured against a similar-size plastic vial, and the release does not say which parts of the Tully Tube still contain plastic. A sustainability lead building a reduction target should model a range, not the ceiling.

Another automation announcement on Nov. 19 shows what a packaging change competes with on a high-volume floor. SpecialtyRx, which describes itself as the nation's largest privately owned long-term care pharmacy, said in a PR Newswire release that it had put Tompkins Robotics' tSort system on the sort-and-scan step that follows a pharmacist's final check. The pharmacy processes more than 55,000 prescriptions a day, and its release led with speed: roughly 1,000 prescriptions per hour by hand against a maximum of 1,400 with tSort, an increase of up to 40 percent per station.

Different step, different setting, and a long-term care pharmacy is not a mail order site. Still, it suggests the yardstick an operations lead is likely to hold a paper vial against. If the Tully Tube ran slower on the HV Wall than a standard vial, the plastic savings would be traded against the very capacity automation is bought to deliver.

What to ask at Booth 145

At the ASHP Midyear Clinical Meeting in Orlando, Dec. 6 to 9, Capsa will display the vials at Booth 145 and give away Tully Tubes branded for RoboPharma. Each giveaway vial is printed with the tagline "Engineering the Future of Pharmacy" next to the RoboPharma by Capsa Healthcare name. That turns the souvenir into a working sample of the custom printing Parcel offers to pharmacies and health systems.

For central fill leaders already running or evaluating RoboPharma, the visit is a chance to move from press release to spec sheet. Three questions get there fastest:

  1. Does the HV Wall fill Tully Tubes at the same rate as standard vials, and which vial sizes are covered by the compatibility confirmation?
  2. What is the plastic reduction for the specific vial sizes our site runs most, measured against the plastic vials we use today?
  3. Can paper vials, paper bags and QR-linked digital medication guides all run on our current Capsa configuration, or does a full paper order need added equipment?

The answers decide whether paper stays a sample in a trade-show tote or becomes a line item in next year's packaging spec. The first public test of that is two weeks away in Orlando.

Featured companies

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

MarketScale Newsroom
MarketScale NewsroomEditorial Team, MarketScale

The MarketScale Newsroom reports on the companies, technologies, and trends shaping 16 B2B industries. It turns primary sources and expert commentary into clear, useful coverage for the people doing the work.

B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

Luminopia's CEO says payer churn slows coverage and can require patching first

Luminopia's CEO says payer churn slows coverage and can require patching first

Luminopia co-founder and CEO Scott Xiao told HLTH's Partner Highlight series that short payer member tenure and a fragmented Medicaid leave pediatric amblyopia neglected. A 2025 JMCP payer roundtable recommended covering the FDA-authorized therapy but allowed step-edits, while PEDIG data show two-hour patching adds about 1.1 lines of acuity. Cleveland Clinic registry data report 1.8 lines of gain in severe cases.

  • 01A 2025 payer roundtable in the Journal of Managed Care & Specialty Pharmacy recommended plans cover Luminopia, yet said step-edits and letters of exception may still be required, with more than 9,000 prescriptions written since November 2022.
  • 02PEDIG's ATS05 trial put two hours of daily patching at 1.1 lines of gain over five weeks versus 0.5 lines for glasses alone, while a 2015 AAO review tied patching's poor compliance to social stigma.
  • 03S.1702, the Access to Prescription Digital Therapeutics Act of 2025, has sat in the Senate Finance Committee since May 8, 2025, leaving coverage negotiated plan by plan.

Nov 19, 2026

AHA and BD's 10-hospital pilot tests who acts on surgical blood pressure readings

AHA and BD's 10-hospital pilot tests who acts on surgical blood pressure readings

The American Hospital Association, West Health and BD will add continuous blood pressure monitoring to surgical care at 10 hospitals, with Vizient measuring results. The pilot tests the workflow around the device: who notices a change, who acts and who hands it off. Whether it spreads depends on cost after startup funding ends.

  • 01A monitor running in two operating rooms can support two different decisions, so device usage counts can say little about whether continuous blood pressure monitoring actually changed surgical care.
  • 02Hospitals evaluating continuous monitoring may already own idle devices; learning why they sit unused, whether training time or an awkward spot in the workflow, points to a different fix than a new purchase order.
  • 03A playbook is expected in roughly a year, aiming to define essential steps while leaving room for smaller or resource-limited hospitals—such as those without 24/7 pharmacy coverage—to adapt workflows locally.

Nov 19, 2026

Four renewal questions that can bring HbA1c closer to the dental chair

Four renewal questions that can bring HbA1c closer to the dental chair

Dr. Deepashree Rajendraprasad, a dentist turned hospital business intelligence developer, gives dental practices four questions for software vendors at contract renewal. They cover HL7 FHIR APIs, health information exchange access, SNODENT terminology and electronic referrals. The standards already exist. The payoff shows up chairside in anticoagulant screening, diabetes-guided periodontal care and bisphosphonate surgical planning.

  • 01Rajendraprasad argues that HbA1c is often already structured in medical systems; getting it to the dental chair starts with what a practice asks its software vendor.
  • 02Two of the five FHIR resources most relevant to dentistry, Patient and Observation, belong to the normative core of FHIR Release 4, where future changes are meant to stay backward compatible.
  • 03At renewal, ask vendors specifics: which FHIR resources they expose, whether they can query the regional HIE, whether they code in SNODENT, and whether they support structured referrals.

Nov 18, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Expert

MarketScale Newsroom
MarketScale Newsroom

Editorial Team

MarketScale

The MarketScale Newsroom reports on the companies, technologies, and trends shaping 16 B2B industries. It turns primary sources and expert commentary into clear, useful coverage for the people doing the work.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512